Merck & Co., Inc.
Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%
Merck Organon — Arcoxia (etoricoxib) Worldwide sales by Year
Organon — Arcoxia (etoricoxib) Worldwide sales ($M) ($M)
Merck Organon — Arcoxia (etoricoxib) Worldwide sales: $265,000,000M in FY2025, down 1.9% from a year earlier.
Where the FY2025 figure comes from
Source: Organon & Co. SEC Filing (0001628280-26-011125) ↗
Reported in Organon & Co. Form 10-Q / 10-K (CIK 0001821825).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Organon — Arcoxia (etoricoxib) Worldwide sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 265,000,000 | -1.9% | Organon & Co. SEC Filing (0001628280-26-011125) ↗ |
| FY2024 | Dec 31, 2024 | 270,000,000 | +5.1% | Organon & Co. SEC Filing (0001821825-25-000006) ↗ |
| FY2023 | Dec 31, 2023 | 257,000,000 | +6.6% | Organon & Co. SEC Filing (0001821825-25-000006) ↗ |
| FY2022 | Dec 31, 2022 | 241,000,000 | -1.2% | Organon & Co. SEC Filing (0001821825-25-000006) ↗ |
| FY2021 | Dec 31, 2021 | 244,000,000 | -5.4% | Organon & Co. SEC Filing (0001821825-23-000003) ↗ |
| FY2020 | Dec 31, 2020 | 258,000,000 | -10.4% | Organon & Co. SEC Filing (0001821825-23-000003) ↗ |
| FY2019 | Dec 31, 2019 | 288,000,000 | – | Organon & Co. SEC Filing (0001821825-22-000002) ↗ |
Breakdown
What makes up organon — Arcoxia (etoricoxib) Worldwide sales
Cite this data
StockData. (2026). Merck Organon — Arcoxia (etoricoxib) Worldwide sales ($M), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/ogn-arcoxia-ww
See every metric in the Merck KPI table. Data updated Oct 26, 2026.